Table 3 Discriminant validity of the CQR5 to identify ≥ 80% adherence by MPR after 1 year of bDMARD treatment
Sensitivity | 89.87% | 84.07–94.10% |
Specificity | 80.76% | 67.46–90.37% |
Area under the curve | 0.85 | 0.79–0.89 |
Positive likelihood ratio | 4.67 | 2.67–8.17 |
Negative likelihood ratio | 0.12 | 0.07–0.20 |
Positive predictive value | 60.90% | 47.09–73.16% |
Negative predictive value | 95.98% | 93.65–97.48% |
Accuracy | 83.04% | 77.27–87.85% |